2022 Olympics: IOC confirms Kamila Valieva's failed drug test. Here's what happens now.

Kamila Valieva
(Image credit: Christine Poujoulat/AFP/Getty Images)

Russian figure skating superstar Kamila Valieva did test positive for the banned substance trimetazidine, the International Testing Agency confirmed Friday on behalf of the International Olympic Committee, and her case will be considered at an expedited hearing of the Court of Arbitration for Sport (CAS) before the women's individual competition begins Feb. 15.

Valieva, 15, already powered the Russian Olympic Committee (ROC) team to gold in the team event, which ended Monday, Feb. 7. Whether Russia gets to keep that gold medal will likely be determined after the Beijing Games end. This weekend's CAS hearing will determine only whether Valieva can participate in the individual event. She is the 2022 European champion and Russian national champion and is heavily favored to win the women's event if she participates. Valieva practiced Thursday and Friday as if she will compete.

Subscribe to The Week

Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.

SUBSCRIBE & SAVE
https://cdn.mos.cms.futurecdn.net/flexiimages/jacafc5zvs1692883516.jpg

Sign up for The Week's Free Newsletters

From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.

From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.

Sign up
To continue reading this article...
Continue reading this article and get limited website access each month.
Get unlimited website access, exclusive newsletters plus much more.
Cancel or pause at any time.
Already a subscriber to The Week?
Not sure which email you used for your subscription? Contact us
Peter Weber, The Week US

Peter has worked as a news and culture writer and editor at The Week since the site's launch in 2008. He covers politics, world affairs, religion and cultural currents. His journalism career began as a copy editor at a financial newswire and has included editorial positions at The New York Times Magazine, Facts on File, and Oregon State University.